Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst
03 Sep Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst
Posted at 19:01h
in
News
by KMFSLLP
U.S. drug prices fell again in
the second quarter, likely due to a new tactic insurers are
using to limit financial assistance drugmakers provide directly
to consumers, according to research firm Sector and Sovereign
Research (SSR).
Sorry, the comment form is closed at this time.